Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Thermo Fisher Scientific Inc. (TMO)

    Price:

    539.17 USD

    ( - -4.78 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    TMO
    Name
    Thermo Fisher Scientific Inc.
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    Price
    539.170
    Market Cap
    203.597B
    Enterprise value
    227.494B
    Currency
    USD
    Ceo
    Marc N. Casper
    Full Time Employees
    125000
    Ipo Date
    1980-03-17
    City
    Waltham
    Address
    168 Third Avenue

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Waters Corporation

    VALUE SCORE:

    6

    Symbol
    WAT
    Market Cap
    18.991B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    2nd position

    Danaher Corporation

    VALUE SCORE:

    7

    Symbol
    DHR
    Market Cap
    149.497B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    The best

    Quest Diagnostics Incorporated

    VALUE SCORE:

    9

    Symbol
    DGX
    Market Cap
    20.350B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    30.955
    P/S
    4.712
    P/B
    4.035
    Debt/Equity
    0.697
    EV/FCF
    37.966
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    5.421
    Earnings yield
    0.032
    Debt/assets
    0.348
    FUNDAMENTALS
    Net debt/ebidta
    2.689
    Interest coverage
    5.242
    Research And Developement To Revenue
    0.033
    Intangile to total assets
    0.616
    Capex to operating cash flow
    0.186
    Capex to revenue
    0.033
    Capex to depreciation
    0.490
    Return on tangible assets
    0.170
    Debt to market cap
    0.173
    Piotroski Score
    7.000
    FUNDAMENTALS
    PEG
    23.014
    P/CF
    26.894
    P/FCF
    32.998
    RoA %
    6.504
    RoIC %
    8.209
    Gross Profit Margin %
    39.579
    Quick Ratio
    1.496
    Current Ratio
    1.933
    Net Profit Margin %
    15.237
    Net-Net
    -89.768
    FUNDAMENTALS PER SHARE
    FCF per share
    16.323
    Revenue per share
    114.317
    Net income per share
    17.418
    Operating cash flow per share
    20.048
    Free cash flow per share
    16.323
    Cash per share
    16.905
    Book value per share
    133.868
    Tangible book value per share
    -31.204
    Shareholders equity per share
    133.627
    Interest debt per share
    97.206
    TECHNICAL
    52 weeks high
    610.970
    52 weeks low
    385.460
    Current trading session High
    549.440
    Current trading session Low
    538.340
    DIVIDEND
    Dividend yield
    0.312%
    Payout ratio
    9.26%
    Years of div. Increase
    8.000
    Years of div.
    14.000
    Q-shift
    1.000
    Dividend per share
    1.680
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0.0071400297%
    Payout Ratio
    22.950819%
    P/E
    32.456
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0.0058913687%
    Payout Ratio
    23.849985%
    P/E
    43.830
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    51.085
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    12.185
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0.0090946%
    Payout Ratio
    42.87183%
    P/E
    48.391
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Plans
    Dividend yield
    0.023656297%
    Payout Ratio
    36.537380000000006%
    P/E
    15.571
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    28.709
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0.013531307%
    Payout Ratio
    32.082695%
    P/E
    24.331
    DESCRIPTION

    Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

    NEWS
    https://images.financialmodelingprep.com/news/thermo-fishers-new-rd-alliance-with-astrazeneca-may-lift-20251007.jpg
    Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock

    zacks.com

    2025-10-07 09:41:05

    TMO joins AstraZeneca's BioVentureHub to boost R&D, innovation and life science access.

    https://images.financialmodelingprep.com/news/top-15-highgrowth-dividend-stocks-for-october-2025-20251001.jpg
    Top 15 High-Growth Dividend Stocks For October 2025

    seekingalpha.com

    2025-10-01 22:58:24

    The Top 15 High-Growth Dividend Stock list for October 2025 targets a 12% long-term return, despite underperforming SPY and VIG in September. These 15 stocks offer a 1.4% average yield and have grown dividends at 19.1% annually over five years, with many trading at significant discounts. Recent changes include six new additions, with expected long-term CAGRs near 20% based on dividend yield theory and valuation metrics.

    https://images.financialmodelingprep.com/news/thermo-fisher-scientific-announces-rd-partnership-with-astrazeneca-bioventurehub-20251001.jpg
    Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub

    businesswire.com

    2025-10-01 10:59:00

    WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub.

    https://images.financialmodelingprep.com/news/thermo-fisher-scientific-to-hold-earnings-conference-call-on-20251001.jpg
    Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025

    businesswire.com

    2025-10-01 08:00:00

    WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before the market opens on Wednesday, October 22, 2025, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. Th.

    https://images.financialmodelingprep.com/news/thermo-fisher-scientific-prices-offering-of-usddenominated-senior-notes-20250930.jpg
    Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

    businesswire.com

    2025-09-30 20:00:00

    WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) of the following notes: $500 million aggregate principal amount of its 4.200% senior notes due 2031 (the “2031 notes”) at the issue price of 99.874% of their principal amount; $750 million aggregate principal amount of its 4.473% senior notes due 2032 (the “2032 notes”) at the issue price of 100.00.

    https://images.financialmodelingprep.com/news/thermo-fisher-scientific-shares-up-33-after-power-inflow-20250930.jpg
    Thermo Fisher Scientific Shares Up 3.3% After Power Inflow Signal

    benzinga.com

    2025-09-30 14:54:39

    Thermo Fisher Scientific Inc (NYSE:TMO) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.At 10:36 AM EST on September 30, TMO triggered a Power Inflow signal at a price of $464.71. Prior to the alert, TMO had been stagnant during the first hour of trading, with the stock price not moving far off the opening price.

    https://images.financialmodelingprep.com/news/thermo-fisher-scientific-showcases-the-thermo-fisher-connect-platform-20250930.jpg
    Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe

    businesswire.com

    2025-09-30 08:30:00

    WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company's Thermo Fisher™ Connect Platform can integrate and future-proof laboratories. From Digital Ambition to Automated Intelligence In pharma and life sciences, digital transformation is no longer a question of if — but how fast. Many labs remain stuck in a cycle of technical debt and shado.

    https://images.financialmodelingprep.com/news/benchsci-announces-strategic-partnership-with-thermo-fisher-scientific-to-20250930.jpg
    BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity

    businesswire.com

    2025-09-30 08:00:00

    TORONTO--(BUSINESS WIRE)--BenchSci today announced a strategic partnership with Thermo Fisher Scientific Inc. to create AI-powered tools to accelerate R&D productivity.

    https://images.financialmodelingprep.com/news/dr-park-cdmo-selects-thermo-fisher-scientific-to-equip-20250924.png
    Dr. Park CDMO Selects Thermo Fisher Scientific to Equip New Viral Vector Manufacturing Facility

    businesswire.com

    2025-09-24 20:00:00

    WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr. Park, an emerging viral vector contract development and manufacturing organization (CDMO) based in South Korea, has selected Thermo Fisher to provide advanced bioreactors and consumables for its newest facility. Dr. Park specializes in Adeno-associated virus-based (AAV-based) viral vector production and currently at 5,000 L per batch, producing up to 40 clinical-grade ba.

    https://images.financialmodelingprep.com/news/thermo-fisher-a-widemoat-leader-with-multiyear-growth-ahead-20250924.jpg
    Thermo Fisher: A Wide-Moat Leader With Multi-Year Growth Ahead

    seekingalpha.com

    2025-09-24 08:37:49

    Thermo Fisher is well positioned as a mission-critical partner in life sciences, with a recurring revenue base and strong end-to-end solutions. The company's strategic acquisitions and leadership in bioprocessing, cell and gene therapy as well as multi-omics reinforce its competitive moat and growth potential. Thermo Fisher's unmatched global distribution drives cross-selling, allowing customers to take advantage of the company's diverse offerings.

    https://images.financialmodelingprep.com/news/holx-vs-tmo-which-diagnostic-giant-is-the-stronger-buy-20250922.jpg
    HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?

    zacks.com

    2025-09-22 10:25:45

    Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.

    https://images.financialmodelingprep.com/news/thermo-fisher-scientific-launches-the-thermo-scientific-hypulse-surface-20250922.jpg
    Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces

    businesswire.com

    2025-09-22 08:30:00

    WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This innovative surface analysis instrument represents a leap forward in accurate X-ray photoelectron spectroscopy (XPS) depth-profiling, which is critical for materials scientists around the world. Innovation to Improve Society The Hypulse Surface Analysis System will enable the development of surfaces across industries to impro.

    https://images.financialmodelingprep.com/news/thirty-inspiring-middle-school-scientists-and-engineers-shine-as-finalists-20250917.png
    Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge

    globenewswire.com

    2025-09-17 12:05:00

    WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 finalists in the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation's premier middle school science, technology, engineering and mathematics (STEM) competition.

    https://images.financialmodelingprep.com/news/the-new-olink-target-48-neurodegeneration-panel-may-boost-20250916.jpg
    The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock

    zacks.com

    2025-09-16 11:46:10

    Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.

    https://images.financialmodelingprep.com/news/thermo-fisher-scientific-expands-neurodegeneration-research-capabilities-with-launch-20250915.jpg
    Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel

    businesswire.com

    2025-09-15 16:15:00

    WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such as Alzheimer's, multiple sclerosis and Parkinson's on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable, r.

    https://images.financialmodelingprep.com/news/thermo-fisher-scientific-inc-tmo-jp-morgan-ceo-call-20250905.jpg
    Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript)

    seekingalpha.com

    2025-09-05 16:49:15

    Thermo Fisher Scientific Inc. J.P. Morgan CEO Call Series September 5, 2025 1:00 PM EDT Company Participants Marc Casper - Chairman, President & CEO Conference Call Participants Rachel Vatnsdal Olson - JPMorgan Chase & Co, Research Division Presentation Operator Welcome, and thank you for standing by.